1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(3-pyrazolidin-4-ylquinoxaline-6-carbonyl)phenyl]urea
C26H20ClF3N6O2 — CID 155903337
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(3-pyrazolidin-4-ylquinoxaline-6-carbonyl)phenyl]urea
1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(3-pyrazolidin-4-ylquinoxaline-6-carbonyl)phenyl]urea (PubChem CID 155903337) has the molecular formula C26H20ClF3N6O2 and a molecular weight of 540.93 g/mol. Its IUPAC name is 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(3-pyrazolidin-4-ylquinoxaline-6-carbonyl)phenyl]urea.
Molecular Properties
| Compound Name | 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(3-pyrazolidin-4-ylquinoxaline-6-carbonyl)phenyl]urea |
|---|---|
| PubChem CID | 155903337 |
| Molecular Formula | C26H20ClF3N6O2 |
| Molecular Weight | 540.93 g/mol |
| Exact Mass | 540.13 |
| IUPAC Name | 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(3-pyrazolidin-4-ylquinoxaline-6-carbonyl)phenyl]urea |
| SMILES | O=C(Nc1cccc(C(=O)c2ccc3ncc(C4CNNC4)nc3c2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1 |
| InChI | InChI=1S/C26H20ClF3N6O2/c27-20-6-5-18(10-19(20)26(28,29)30)35-25(38)34-17-3-1-2-14(8-17)24(37)15-4-7-21-22(9-15)36-23(13-31-21)16-11-32-33-12-16/h1-10,13,16,32-33H,11-12H2,(H2,34,35,38) |
| InChIKey | JRWRYJIWXIJBKH-UHFFFAOYSA-N |
| XLogP | 5.37 |
| TPSA | 108.04 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 540.93 |
| LogP ≤ 5 | 5.37 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155903337 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.